Xiaoqi W. Wang
State Key Laboratory Of Trauma And Chemical Poisoning
Chongqing, China
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.
Journal: Science translational medicine
Published: July 01, 2026
Lignin-derived fulvic acid-like substances from spent pulping liquor enhanced rice salt tolerance via K+/Na+ homeostasis modulated by plasma membrane H+-ATPase.
Journal: Bioresource technology
Published: May 19, 2026
Emerging strategies for the prevention and management of chronic graft-versus-host disease.
Journal: Expert opinion on biological therapy
Published: April 22, 2026
Patient-reported outcomes in chronic GVHD: instruments, clinical utility, and survivorship integration.
Journal: Journal of patient-reported outcomes
Published: January 02, 2026
Lignite-enhanced aerobic composting of acidified soybean soapstock by-products: reducing carbon and nitrogen loss and accelerating composting process.
Journal: Waste management (New York, N.Y.)
Published: September 24, 2025
Keratin 8 enhances the efficacy of mesenchymal stem cells in preventing acute graft-versus-host disease.
Journal: Chinese medical journal
Published: September 19, 2025
Recipient-derived vs. donor-derived CAR-T-cell therapy in relapsed B-cell acute lymphoblastic leukemia patients after transplantation: A multi-center retrospective study.
Journal: Chinese medical journal
Published: August 11, 2025
Approved and emerging therapies for glucocorticoid-refractory chronic graft-versus-host disease.
Journal: Current opinion in immunology
Published: June 24, 2025
Mesenchymal Stromal Cells and Graft-versus-Host Disease: Preclinical and Clinical Studies.
Journal: Stem cell reviews and reports
Published: June 03, 2025
Connexin 43 promotes stemness of leukemia cells and chemoresistance in T-cell acute lymphoblastic leukemia via the RAC1/AKT/GSK3β axis.
Journal: Chinese medical journal
Published: May 11, 2025
Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 15, 2025
Last Updated: 09/26/2026